Atridia Pty Ltd.
Clinical trials sponsored by Atridia Pty Ltd., explained in plain language.
-
New obesity drug HRS-5817 enters early human testing
Disease control OngoingThis early-phase study tests a single injection of HRS-5817 in 40 obese adults aged 18-55 with a BMI of 30-40. The main goal is to check safety and side effects, not to cure obesity. Researchers will also measure how the drug moves through the body and how the immune system respo…
Phase: EARLY_PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
New psoriasis drug candidate begins first human safety tests
Knowledge-focused OngoingThis early-stage study tests a single dose of SHR-1139 in 24 healthy adults to check its safety, how the body processes it, and whether it triggers an immune response. The goal is to gather basic information before testing it in people with psoriasis. No treatment benefit is expe…
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:37 UTC